|
|
 |
|
This exciting Internet webcast begins with Brian J. Druker, MD, discussing the progress of CML therapy for newly diagnosed CML patients, and continues with an overview by Neil P. Shah, MD, PhD, as he reviews new therapies for relapsed/refractory CML patients. This program for patients with CML, caregivers and healthcare professionals is sponsored by The Leukemia & Lymphoma Society through an unrestricted educational grant from Novartis Oncology.
|
|
|
|
|

|
|
|
|
| Sponsored by: |
Supported by an unrestricted educational grant from:
|
|
|
|
|